Micrus endovascular coils mri safety guidelines

Comparing a new approved endovascular coil device (Cerecyte) with existing platinum coil devices to produce occlusion of the aneurysm on follow-up angiography at 6 months 3. The patient will also have MRI angiography at 1 year Amendments to interventions as of 30/05/2006: 1.

Inside each CERECYTE Microcoil, a stretch-resistant polyglycolic acid (PGA) element is uniquely positioned within the primary wind of the coil. It's Responsive. Induced tissue response* provides support for neointimal formation across the aneurysm neck with handling and packing volume equivalent to Micrus bare platinum coils. The Inside Advantage San Jose, CA-based Micrus Endovascular has received Shonin approval to market in Japan its novel bare platinum and Cerecyte DeltaPaq filling and DeltaPlush finishing microcoils for the treatment We describe a case of a very unusual complication following a coiling procedure in which the patient developed transient unique cerebral and cerebellar lesions. Lesions were examined not only by magnetic resonance imaging (MRI) but also by positron emission tomography-computed tomography (PET-CT) and proton magnetic resonance spectroscopy (1H-MRS). June 23, 2011 — A new study published in the June edition of the Journal of NeuroInterventional Surgery highlights that a more uniform distribution of endovascular coils may help in the treatment of cerebral aneurysms. Deltapaq endovascular microcoils from Codman & Shurtleff Inc., a global neurovascular and neuroscience company, were used in the study. AccessGUDID - MICRUSPHERE CERECYTE (00878528001027)- MICRUSPHERE microcoil MICRUSPHERE 10 CERECYTE Coil 3mm x 5.4cm 190cm Contents: 1 Detachable Coil System. Skip to Main Content; What MRI safety information does the labeling contain? BACKGROUND AND PURPOSE: Recanalization remains a major drawback in the endovascular treatment of intracranial aneurysms. Here, we report on our preliminary clinical experience with a new bioactive coil. PATIENTS AND METHO